Clinical Trials Browser

Embolism, Neoplasms, Venous Thromboembolism

NCT05029063 2025-07-09

TRIM-Line

Phase 3 Recruiting

1,828 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

NCT06284343 2024-09-19

GynCAT

Recruiting

1,800 enrolled

Classical hematologyGynecologic

Uterine Cervical Neoplasms, Neoplasms, Ovarian Neoplasms, Thrombosis, Vaginal Neoplasms, Endometrial Neoplasms, Venous Thromboembolism

NCT02744092 2023-10-03

CANVAS

Phase NA Completed

811 enrolled 19 charts

Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT05461807 2022-10-26

H2H-OSCAR-US

Completed

2,437 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

NCT04999176 2021-08-10

VALERIA

Phase 3 Unknown

440 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

NCT02583191 2021-05-03

Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients

Phase 3 Terminated

246 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

NCT02555878 2019-09-12

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

Phase 3 Completed

841 enrolled 24 charts

Classical hematology

Neoplasms, Venous Thromboembolism

NCT02746185 2018-08-13

CASTA-DIVA

Phase 3 Completed

159 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

Clinical Trials

VICTORIE

TRIM-Line

GynCAT

CANVAS

H2H-OSCAR-US

VALERIA

Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

CASTA-DIVA